(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.78%) $83.20
(1.14%) $1.945
(-0.25%) $2 341.40
(0.18%) $27.59
(0.73%) $928.80
(-0.27%) $0.932
(-0.31%) $10.99
(-0.36%) $0.797
(0.25%) $92.11
-41.94% US12542Q70 0.168
Live Chart Being Loaded With Signals
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics...
Stats | |
---|---|
Dagens volum | 18.26M |
Gjennomsnittsvolum | 1.27M |
Markedsverdi | 1.14M |
EPS | US12542Q700 ( 2024-03-05 ) |
Neste inntjeningsdato | ( US12542Q70-0.930 ) 2024-05-14 |
Last Dividend | US12542Q700 ( N/A ) |
Next Dividend | US12542Q700 ( N/A ) |
P/E | -0.0100 |
ATR14 | US12542Q700.00100 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Mccormick Michael Kendrick | Buy | 20 836 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Mcdonald David | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Feldshon Archelle Georgiou | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2023-11-01 | Mcdonald David | Buy | 0 | |
2023-11-01 | Feldshon Archelle Georgiou | Buy | 0 |
INSIDER POWER |
---|
97.91 |
Last 90 transactions |
Buy: 3 285 386 | Sell: 12 287 |
Volum Korrelasjon
Nuwellis, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Nuwellis, Inc. Korrelasjon - Valuta/Råvare
Nuwellis, Inc. Økonomi
Annual | 2023 |
Omsetning: | US12542Q708.86M |
Bruttogevinst: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2023 |
Omsetning: | US12542Q708.86M |
Bruttogevinst: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2022 |
Omsetning: | US12542Q708.54M |
Bruttogevinst: | US12542Q704.76M (55.66 %) |
EPS: | US12542Q70-83.48 |
FY | 2021 |
Omsetning: | US12542Q707.92M |
Bruttogevinst: | US12542Q704.49M (56.70 %) |
EPS: | US12542Q70-285.73 |
Financial Reports:
No articles found.
Nuwellis, Inc.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.